Prostate Cancer

Implant Sciences Awarded Over $1,000,000 In Government Contracts

Published in Cancer Weekly, November 6th, 2001

Implant Sciences Corp. (IMX), which manufactures I-Plant Iodine-125 brachytherapy seeds for the treatment of prostate cancer has been awarded four government contracts and grants totaling approximately $1,050,000 from the National Institutes of Health (NIH) and the Department of Defense (DOD).

The NIH grants involve the treatment of spinal cancer and ocular melanoma (eye cancer) using the company's proprietary radioactive implant technology. The DOD contract is for the development of miniature toxic gas sensors to be worn by firefighters to sense whether the air in a specific area is safe to breathe. The company expects to recognize approximately $500,000 of these...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2001-11-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry